GlassScriptPhysician profile
Ahmed M Elwan
NPI 1346575602
$13,402.27
in general payments reported to CMS, 2019-2025
32 companies · $2,514 in 2025
The $2,514 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $667 · 2021: $1,316 · 2022: $2,604 · 2023: $2,413 · 2024: $2,820 · 2025: $2,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,747.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,863.58 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $1,855.97 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $1,731.95 | 2019-2024 | Xarelto |
| Abbott Laboratories | $989.82 | 2020-2025 | Jot Dx, Gallant, Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $973.65 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $689.88 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $639.60 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $623.37 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $390.95 | 2019-2025 | Farxiga, Wainua |
| Impulse Dynamics (USA) INC. | $314.90 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $306.32 | 2022-2025 | Verquvo, Winrevair |
| Lexicon Pharmaceuticals, INC. | $282.70 | 2023-2024 | Inpefa |
| Boston Scientific Corporation | $271.07 | 2022-2024 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $257.01 | 2022-2025 | Amvuttra, Onpattro |
| Lilly USA, LLC | $159.12 | 2023-2025 | Mounjaro, Zepbound |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $136.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $126.73 | 2023-2025 | |
| Heartflow, INC. | $124.38 | 2025 | |
| Biotronik INC. | $112.24 | 2022 | |
| Medtronic, INC. | $83.19 | 2025 | Symplicity G3 |
| Sanofi-Aventis U.S. LLC | $80.39 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $62.72 | 2019 | |
| Bridgebio Pharma, INC. | $54.00 | 2025 | Attruby |
| Baxter Healthcare | $45.81 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Scpharmaceuticals INC. | $35.71 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $33.60 | 2025 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $32.22 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $28.16 | 2019-2021 | |
| Daiichi Sankyo INC. | $27.61 | 2023 | Injectafer |
| Upsher-Smith Laboratories LLC | $25.28 | 2025 | |
| Bracco Diagnostics INC. | $24.29 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $19.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Elwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.